Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T22:22:44.088Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of quetiapine on cognitive function in schizophrenia: a mismatch negativity potentials study

Published online by Cambridge University Press:  24 June 2014

Guo-zhen Yuan ,
Zhen-he Zhou  and
Jian-jun Yao
Guo-zhen Yuan
Affiliation:
Department of Psychiatry, Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China
Zhen-he Zhou*
Affiliation:
Department of Psychiatry, Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China
Jian-jun Yao
Affiliation:
Department of Psychiatry, Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China
*
Professor Zhen-he Zhou, Department of Psychiatry, Wuxi Mental Health Center of Nanjing Medical University, Wuxi 214151, China. Tel: +86-510-13358118986; Fax: +86-510-83015825; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The purpose of this study was to investigate whether the effects of quetiapine on abnormalities of early auditory processing in patients with schizophrenia were reflected by mismatch negativity (MMN).

Methods:

Subjects were 23 patients with schizophrenia and 23 controls. Psychopathology was rated in patients with the Positive and Negative Syndrome Scale (PANSS) at baseline and after 4-week and after 8-week treatments with quetiapine. Auditory stimuli for event-related potentials consisted of 100 ms/1000 Hz standards, intermixed with 100 ms/1500 Hz frequency deviants and 250 ms/ 1000 Hz duration deviants. A stimulus onset asynchrony of each was 300 ms. Electroencephalograph was recorded at Fz. BESA 5.1.8 was used to perform data analysis. MMN waveforms were obtained by subtracting waveforms elicited by standards from those elicited by frequency- or duration-deviant stimuli.

Results:

Quetiapine decreased all PANSS scores. Patients showed smaller mean amplitudes of frequency and duration MMN at baseline than did controls. A repeated measure analysis of variance with sessions (i.e. baseline and 4- and 8-week treatments) and MMN type (frequency versus duration) as within-subject factors revealed no significant MMN type or MMN type × session main effect for MMN amplitudes (for MMN type: F = 0.704, df = 1, p = 0.403; for MMN type × session: F = 0.299, df = 2, p = 0.796). Session main effect was significant (F = 3.576, df = 2, p = 0.031). Least square difference tests showed significant differences between MMN amplitudes at 8 weeks and those at both baseline (p = 0.025) and 4 weeks (p = 0.020). MMN amplitudes at 8 weeks were higher than those at baseline.

Conclusions:

Quetiapine improved the amplitudes of MMN after the 8-week treatment. MMN offers objective evidence that treatment with the quetiapine may ameliorate preattentive deficits in schizophrenia.

Keywords

cognitive functionmismatch negativityquetiapineschizophrenia
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 21 , Issue 1 , February 2009 , pp. 26 - 33
Copyright
Copyright © 2009 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bilder, RM, Goldman, RS, Robinson, Det al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000;157:549–559. CrossRefGoogle ScholarPubMed
Bema, BK, Kfksal, AA, Haluk, Aet al. Effects of quetiapine on cognitive functions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:233–238. Google Scholar
Green, MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321–330. Google ScholarPubMed
Meltzer, HY, Thompson, PA, Lee, MAet al. Neuropsychological deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Prog Neuropsychopharmacol 1996;14:27S–33S. CrossRefGoogle ScholarPubMed
Velligan, DI, Miller, AL. Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment. J Clin Psychiatry 1999;60:S25–S28. Google ScholarPubMed
Sharma, T. Quetiapine–efficacy in different domains. Eur Neuropsychopharmacol 2001;11:385–390. CrossRefGoogle ScholarPubMed
Purdon, SE, Malla, A, Labelle, Aet al. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 2001;26:137–149. Google ScholarPubMed
Velligan, DJ, Newcomer, J, Pultz, Jet al. Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 2002;53:239–248. CrossRefGoogle ScholarPubMed
Meisenzahl, EM, Scheuerecker, J, Zipse, Met al. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Eur Arch Psychiatry Clin Neurosci 2006;256:522–531. CrossRefGoogle ScholarPubMed
Velligan, DI, Prihoda, TJ. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 2003;64:524–531. CrossRefGoogle ScholarPubMed
Jones, HM, Brammer, MJ, Toole, Met al. Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biol Psychiatry 2004;56:938–942. CrossRefGoogle ScholarPubMed
Daniel, SG, Umbricht, JA, Bates, JAet al. Electrophysiological indices of automatic and controlled auditory information processing in first-episode recent-onset and chronic schizophrenia. Biol Psychiatry 2006;59:762–772. Google Scholar
Naatanen, R. The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hear 1995;16:6–18. CrossRefGoogle ScholarPubMed
Alain, C, Woods, DL. Attention modulates auditory pattern memory as indexed by event-related brain potentials. Psychophysiology 1997;34:534–546. CrossRefGoogle ScholarPubMed
Dittmann-Balcar, A, Thienel, R, Schall, U. Attention-dependent allocation of auditory processing resources as measured by mismatch negativity. Neuroreport 1999;10:3749–3753. CrossRefGoogle ScholarPubMed
Woldorff, MG, Hillyard, SA, Gallen, CCet al. Magnetoencephalographic recordings demonstrate attentional modulation of mismatch-related neural activity in human auditory cortex. Psychophysiology 1998;35:283–292. CrossRefGoogle ScholarPubMed
Lavoie, S, Murray, MM, Deppen, Pet al. Glutathione precursor N-Acetyl-Cysteine, improves mismatch negativity in schizophrenia patients. Prog Neuropsychopharmacol 2007;11:1–13. Google Scholar
Umbricht, D, Krljes, S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 2005;76:1–23. CrossRefGoogle ScholarPubMed
Anke, BD, Indira, T, Ralf, Pet al. Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr Res 2005;73:297–310. Google Scholar
Javitt, DC, Shelley, AM, Silipo, Get al. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch Gen Psychiatry 2000;57:1131–1137. CrossRefGoogle ScholarPubMed
Salisbury, DF, Shenton, ME, Grigge, CBet al. Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Arch Gen Psychiatry 2002;59:686–694. CrossRefGoogle ScholarPubMed
Umbricht, D, Koller, R, Schmid, Let al. How specific are deficits in mismatch negativity generation to schizophrenia? Biol Psychiatry 2003;53:1120–1131. CrossRefGoogle ScholarPubMed
Baldeweg, T, Richardson, A, Watkins, Set al. Impaired auditory frequency discrimination in dyslexia detected with mismatch evoked potentials. Ann Neurol 1999;45:495–503. 3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Ilvonen, TM, Kujala, T, Tervanieme, Met al. The processing of sound duration after left hemisphere stroke: event-related potential and behavioral evidence. Psychophysiology 2001;38:622–628. Google ScholarPubMed
Kujala, T, Lepisto, T, Nieminen-Von Wendt, Tet al. Neurophysiological evidence for cortical discrimination impairment of prosody in Asperger syndrome. Neurosci Lett 2005;383:260–265. CrossRefGoogle ScholarPubMed
Pekkonen, E, Hirvonen, J, Jaaskelamen, IPet al. Auditory sensory memory and the cholinergic system: implications for Alzheimer’s disease. Neuroimge 2001;14:376–382. CrossRefGoogle ScholarPubMed
Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–271. CrossRefGoogle ScholarPubMed
Annett, M. A classification of hand preference by association analysis. Br J Psychiatry 1970;61:303–321. Google ScholarPubMed
Sato, Y, Yabe, H, Hiruma, Tet al. The effect of deviant stimulus probability on the human mismatch process. Neuroreport 2000;11:3703–3708. CrossRefGoogle ScholarPubMed
Yago, E, Escera, C, Alho, Ket al. Cerebral mechanisms underlying orienting of attention towards auditory frequency changes. Neuroreport 2001;12:2583–2587. CrossRefGoogle ScholarPubMed
Dittmann, BA, Juptner, M, Jentzen, Wet al. Dorsolateral prefrontal cortex activation during automatic auditory duration-mismatch processing in humans: a positron emission tomography study. Neurosci Lett 2001;308:119–122. CrossRefGoogle Scholar
Michie, PT, Innes-Brown, H, Todd, Jet al. Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders. Biol Psychiatry 2002;52:749–758. CrossRefGoogle ScholarPubMed
Elvira, B, Croft, RJ, McDonald, Cet al. Mismatch negativity in schizophrenia: a family study. Schizophr Res 2004;67:1–10. Google Scholar
Saykin, AJ, Gur, RC, Gur, REet al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991;48:618–624. CrossRefGoogle ScholarPubMed
Gold, JM, Harvey, PD. Cognitive deficits in schizophrenia. Psychiatr Clin North Am 1993;16:295–312. CrossRefGoogle ScholarPubMed
Velligan, DI, Mahurin, RK, Diamond, DL. The functional significance of symptomatology and cognitive function in schizophre-nia. Schizophr Res 1997;25:21–31. CrossRefGoogle Scholar
Umbricht, D, Javitt, D, Novak, Get al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry 1998;44:716–725. CrossRefGoogle ScholarPubMed
Umbricht, D, Javitt, D, Novak, Get al. Effects of risperidone on auditory event-related potentials in schizophrenia. Int J Neuropsychopharmacol 1999;2:299–304. CrossRefGoogle ScholarPubMed
Korostenskaja, M, Dapsys, K, Siurkute, Aet al. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuropsychopharmacol 2005;29:543–548. CrossRefGoogle ScholarPubMed
Naatanen, R, Paavilainen, P, Alho, Ket al. Do event-related potentials reveal the mechanism of the auditory sensory memory in the human brain? Neurosci Lett 1989;98:217–221. CrossRefGoogle ScholarPubMed
Malhi, GS, Lagopoulos, J. Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand 2008;117:100–117. CrossRefGoogle Scholar